SB756050
Catalog No. A12759
SB756050 is a selective TGR5 agonist currently in phase 1clinical trials for the treatment of type 2 diabetes.
Catalog Num | A12759 |
---|---|
M. Wt | 500.59 |
Formula | C21H28N2O8S2 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 447410-57-3 |
Synonyms | SB-756050; SB 756050 |
SMILES | O=S(N1CCN(S(=O)(C2=CC=C(OC)C(OC)=C2)=O)CCC1)(C3=CC=C(OC)C(OC)=C3)=O |
SB756050 is a selective TGR5 agonist currently in phase 1clinical trials for the treatment of type 2 diabetes.
In vitro | DMSO | 91 mg/mL (181.78 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.98 mL | 99.88 mL | 199.76 mL |
0.5 mM | 4 mL | 19.98 mL | 39.95 mL |
1 mM | 2 mL | 9.99 mL | 19.98 mL |
5 mM | 0.4 mL | 2 mL | 4 mL |
*The above data is based on the productmolecular weight 500.59. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.